Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Buruli ulcer: emerging from obscurity.

Mark Wansbrough-Jones1, Richard Phillips

  • 1St George's University of London, London, UK. wansbrou@sgul.ac.uk

Lancet (London, England)
|June 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real particle physics analysis by UK secondary school students using the ATLAS Open Data: an illustration through a collection of original student research.

European physical journal plus·2026
Same author

Methods to Improve Confidence in the Accuracy of Molecular Testing for Multidrug-Resistant Tuberculosis.

Clinical chemistry·2026
Same author

Nutrient-stimulated Hormone-based Therapies: A New Frontier in the Prevention and Management of MASH-associated Hepatocellular Carcinoma.

Journal of clinical and translational hepatology·2025
Same author

Commercial Learning Platforms in UK Undergraduate Medical Education: A Qualitative Study of Benefits, Limitations, and Integration.

Advances in medical education and practice·2025
Same author

Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodology.

British journal of cancer·2025
Same author

Clinical epidemiology of Buruli ulcer disease in Ghana, 2006-2024.

Clinical and experimental dermatology·2025
Same journal

Convergence of metabolic risk in obesity and normal BMI: does risk disappear?

Lancet (London, England)·2026
Same journal

Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.

Lancet (London, England)·2026
Same journal

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

Lancet (London, England)·2026
Same journal

The US Ebola response and the future of global health leadership.

Lancet (London, England)·2026
Same journal

Daniel Mason: a tale of change.

Lancet (London, England)·2026
Same journal

The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?

Lancet (London, England)·2026
See all related articles

Buruli ulcer, a skin disease caused by Mycobacterium ulcerans, is characterized by its unique toxin, mycolactone. Recent advances include understanding its genome, transmission, and improved antibiotic therapy for this debilitating condition.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Dermatology

Background:

  • Buruli ulcer is a neglected tropical skin disease caused by Mycobacterium ulcerans.
  • The disease is distinguished by mycolactone, a toxin produced by M. ulcerans that destroys subcutaneous tissue, leading to large ulcers.
  • The exact mode of transmission remains unclear, though environmental sources are increasingly understood.

Purpose of the Study:

  • To summarize the current understanding of Mycobacterium ulcerans and its relationship with human health.
  • To highlight recent advancements in the study and management of Buruli ulcer.

Main Methods:

  • Review of current scientific literature on Mycobacterium ulcerans.
  • Analysis of genomic data, including plasmid-borne toxin genes.

Related Experiment Videos

  • Synthesis of information on disease transmission, immune response, and therapeutic strategies.

    • Main Results:

    • The genome of M. ulcerans has been sequenced, revealing two identical plasmids carrying the mycolactone genetic code.
    • Environmental sources of M. ulcerans are better understood, though transmission routes are still uncertain.
    • Significant progress has been made in understanding the immune response and developing effective antibiotic therapies.

    Conclusions:

    • Mycobacterium ulcerans infection leads to Buruli ulcer through mycolactone-induced tissue destruction.
    • Advances in genomics and therapy offer new hope for managing this disease.
    • Further research into transmission is crucial for effective prevention strategies.